Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.43+0.01 (+0.70%)
Close on Nov 18, 2026Market cap $53.52MP/E –Yield –
Tenax Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Tenax Therapeutics's shares outstanding was 51M at Jun 30, 2026. For fiscal 2025 it was 39M, up 156.8% from the year before. Over ten years it grew 84.0% a year on average. The highest annual figure on record is 39M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 39M | +156.8% |
| FY2024 | Dec 31, 2024 | 15M | +6046.9% |
| FY2023 | Dec 31, 2023 | 0M | -98.8% |
| FY2021 | Dec 31, 2021 | 21M | +98.5% |
| FY2020 | Dec 31, 2020 | 10M | +67.3% |
| FY2019 | Dec 31, 2019 | 6M | +295.9% |
| FY2018 | Dec 31, 2018 | 2M | +10.9% |
| FY2017 | Dec 31, 2017 | 1M | +0.5% |
| FY2015 | Apr 30, 2015 | 1M | +199.9% |
| FY2014 | Apr 30, 2014 | 0M | +432.2% |
| FY2013 | Apr 30, 2013 | 0M | +26.8% |
| FY2012 | Apr 30, 2012 | 0M | +18.9% |
| FY2011 | Apr 30, 2011 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | 51M | +28.5% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 45M | +23.6% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 41M | +93.4% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 40M | +1929.4% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | 40M | +3145.9% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | 37M | +44.9% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 21M | -16.0% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 2M | -88.6% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | 1M | -91.6% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | 25M | +99.0% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | 25M | +102.8% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | 17M | +84.4% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | 15M | +108.1% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | 13M | +88.1% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | 12M | +84.4% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | 9M | +46.3% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | 7M | +42.7% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | 7M | +251.5% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | 7M | +361.0% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | 6M | +339.3% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | 5M | +243.5% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | 2M | +36.0% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | 1M | +3.6% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | 1M | +3.0% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | 1M | +1.1% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | 1M | +0.4% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | 1M | +0.4% |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | 1M | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | 1M | – |
| Q4 FY2015CQ1 2015 | Apr 30, 2015 | 1M | – |
| Q3 FY2015CQ4 2014 | Jan 31, 2015 | 1M | – |
See a number that looks wrong?